© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#COVID-19 treatment

Two scientists cooperating while examining antiviral drug in a test tube at laboratory
FDA Approves Remdesivir for Hospitalized COVID-19 Patients
coronavirus
NIH Study Aims To Identify Promising COVID-19 Treatments for Larger Trials
Senior patient in hospital bed nurse
How is COVID-19 treated?
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

Is COVID-19 PrEP on the Horizon?

Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.

Interferon Does Not Improve Outcomes for Hospitalized Adults with COVID-19

Treatment with interferon beta-1a plus the antiviral remdesivir was not superior to remdesivir alone.
Molnupiravir capsules (Merck)

Oral Antiviral Drug Cuts COVID-19 Hospitalization in Half

Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
National Institutes of Health director Francis Collins, MD, PhD

Francis Collins to Step Down as Director of the National Institutes of Health

Collins has led the NIH under three presidents over more than 12 years.

Will ‘Dr. Disinformation’ Ever Face the Music?

A steady stream of spurious claims about COVID-19 vaccines and treatments swirl around the public consciousness.

New Concerns About Coronavirus Evolution in Immunosuppressed Patients

Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.

Biden Administration Will Invest $3 Billion for COVID-19 Antiviral Development

The government-wide effort aims to develop the next generation of COVID-19 treatments to prepare the U.S. to respond to future virus threats

Airway-on-a-Chip Screens Drugs for Use Against COVID-19

Researchers used an airway-on-a-chip that mimics living lung tissue to screen approved drugs for use against SARS-CoV-2.

Oral Antiviral Drug Effective Against COVID-19 in Hamsters

Molnupiravir, previously studied for hepatitis C, might be able to prevent or treat COVID-19 outside of a clinical setting.
AIDS activists at 1990 International AIDS Conference in San Francisco

Four Ways HIV Activists Have Saved Lives During COVID

We owe these early fighters a debt of gratitude for transforming our response to public health crises.

New COVID-19 Treatment Advice and Vaccine Guidance for Cancer Patients

Experts provide recommendations for both treatment and prevention of COVID-19 for people with cancer.
Fatima Hassan and Gregg Gonsalves call for global COVID-19 vaccine access at CROI 2021 opening plenary

Advocates Call for Global Access to COVID-19 Vaccines

At the current pace, only about 20% of the world’s population will be vaccinated by the end of 2021.
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

Bamlanivimab and etesevimab may be given to people with mild to moderate COVID-19 who are at high risk for progression to severe disease.

Patients Fend for Themselves to Access Highly Touted COVID Antibody Treatments

Even as drugmakers ramp up supplies, only a trickle of the product has found its way into regular people.
Sea squirt

Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including New Variants

Plitidepsin, derived from a sea squirt, may be far more potent than remdesivir against the coronavirus.

Full-Dose Blood Thinners Improve Outcomes for Hospitalized COVID-19 Patients

Full-dose anticoagulation treatment for moderately ill COVID-19 patients reduced the need for ventilators.
Advertisement
Ask COVID Health
Features